The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Diagnostics and treatment for HER2+ mG&CRC: Learning outcomes of GetSMART.
 
Emil Lou
Honoraria - Boston Scientific; Daiichi Sankyo/UCB Japan (Inst); GlaxoSmithKline; Novocure
Consulting or Advisory Role - Boston Scientific; Novocure; Novocure; Novocure; Novocure
Research Funding - Intima; Novocure
Travel, Accommodations, Expenses - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Caris Life Sciences; Minnetronix Medical; NomoCan
 
John Marshall
Employment - Caris Life Sciences; Indivumed
Leadership - 2curex
Honoraria - Bayer/Onyx; Caris Life Sciences; Daiichi Sankyo/Lilly; Merck; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bayer/Onyx; Caris Life Sciences; Celgene; Genentech/Roche; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Bayer/Onyx; Merck; Taiho Pharmaceutical
 
Ginny Jacobs
No Relationships to Disclose
 
Matthew Fleming
No Relationships to Disclose
 
Anelisa Kruschewsky Coutinho
Employment - AMO DASA
Stock and Other Ownership Interests - AMO / GEM Oncology Institution
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; BMS Bristol; Daichii; GeneOne Life Science Inc; Ipsen; Libbs; Lilly; Merck Serono; MSD Oncology; Natera; Roche/Genentech; Sanofi/Aventis; SERVIER; United Medical
Speakers' Bureau - Amgen; AstraZeneca; Bayer; BMS Brazil; Daiichi SAYO; Ipsen; Lilly; Merck Serono; MSD Oncology; Novartis; Roche Molecular Diagnostics; Roche/Genentech; Sanofi/Aventis; SERVIER; United Medical
Research Funding - Bristol-Myers Squibb (Inst); SERVIER (Inst)
 
Takayuki Yoshino
Honoraria - Bayer Yakuhin; Chugai Pharma; Merck; MSD K.K.; Ono Pharmaceutical
Research Funding - Amgen (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); Genomedia (Inst); MSD (Inst); Nippon Boehringer Ingelheim (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Sysmex (Inst); Taiho Pharmaceutical (Inst)
 
Monica Augustyniak
No Relationships to Disclose
 
Pam McFadden
No Relationships to Disclose